EUVIMEDSkopri EUVIMED
Qualitative StudieOpen access · CC BY-NC-ND 4.0

General practitioners’ perceptions of the provision of direct-acting antivirals for hepatitis C within Australian private general practice: an exploratory qualitative study

Jane Scarborough, Paul Aylward, Emma Ruth Miller

Australian Journal of Primary Health · 2023

DOI: 10.1071/py22271 ↗

At a glance

Qualitative Studie in Australian Journal of Primary Health, 2023. Written by Jane Scarborough and 2 co-authors. Institution: College of Medicine and Public Health, Flinders University, Sturt Road, Bedford Park, SA 5042, Australia. Major MEDLINE topics: General Practitioners, Hepatitis C, Chronic, General Practice. Cited 1 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

There is a need to increase the involvement of Australian general practitioners (GPs) working in private practice to realise the potential of direct-acting antiviral (DAA) treatments for people with the hepatitis C virus.

Methods

Semi-structured interviews were conducted in 2018 with seven GPs and two practice nurses working in private general practice to elicit the experiences and perceptions of their involvement in providing care for patients with hepatitis C virus in this setting. The interviews were recorded, transcribed and thematically analysed to inform interventions to maximise the provision of DAA in private general practice.

Results

Participants described individual GPs purposely limiting their scope of clinical practice (SOCP) and expressed an expectation that DAA provision would not be included in all GP’s SOCP. When GPs delineate their SOCP, their confidence to competently provide quality health care to their patients and GPs’ professional special interests are important considerations.

Conclusion

Providing DAA training, skill development, support and resources to GPs is necessary, but may not ensure that individual private GPs will provide this care. Where GPs do not include DAA in their SOCP, care pathways need to be developed for patients who will benefit from DAA, including GP-to-GP referral. These findings may be applicable to other areas of unmet need that rely on GPs including provision of care in their SOCP.

Subjects

MeSH terms (MEDLINE)

General PractitionersHepatitis C, ChronicGeneral PracticeHumansAntiviral AgentsAustraliaHepacivirusQualitative ResearchPrivate PracticeAttitude of Health Personnel

Substances

Antiviral Agents

Authors and institutions

  • College of Medicine and Public Health, Flinders University, Sturt Road, Bedford Park, SA 5042, Australia.
  • Research Centre for Public Health, Equity and Human Flourishing, Torrens University Australia, Adelaide, SA 5000, Australia.
  • Stretton Institute, The University of Adelaide, North Terrace Campus, Adelaide, SA 5005, Australia.

Cite

APA

Scarborough, J., Aylward, P., & Miller, E. R. (2023). General practitioners’ perceptions of the provision of direct-acting antivirals for hepatitis C within Australian private general practice: an exploratory qualitative study. Australian Journal of Primary Health. https://doi.org/10.1071/py22271

Vancouver

Scarborough J, Aylward P, Miller ER. General practitioners’ perceptions of the provision of direct-acting antivirals for hepatitis C within Australian private general practice: an exploratory qualitative study. Australian Journal of Primary Health. 2023. doi:10.1071/py22271

BibTeX
@article{Scarborough2023,
  author = {Scarborough, Jane and Aylward, Paul and Miller, Emma Ruth},
  title = {General practitioners’ perceptions of the provision of direct-acting antivirals for hepatitis C within Australian private general practice: an exploratory qualitative study},
  journal = {Australian Journal of Primary Health},
  year = {2023},
  doi = {10.1071/py22271}
}
Start for free →